BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23222893)

  • 1. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.
    Leventhal J; Abecassis M; Miller J; Gallon L; Tollerud D; Elliott MJ; Bozulic LD; Houston C; Sustento-Reodica N; Ildstad ST
    Transplantation; 2013 Jan; 95(1):169-76. PubMed ID: 23222893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
    Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
    Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
    Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
    Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
    Leventhal JR; Ildstad ST
    Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
    Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
    Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.
    Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST
    Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.
    Annamalai C; Kute V; Sheridan C; Halawa A
    Transplant Rev (Orlando); 2023 Dec; 37(4):100792. PubMed ID: 37709652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation.
    Senev A; Tambur AR; Kosmoliaptsis V; Copley HC; García-Sánchez C; Usenko C; Ildstad ST; Leventhal JR
    Front Immunol; 2024; 15():1377535. PubMed ID: 38601147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.
    Luznik L; Jalla S; Engstrom LW; Iannone R; Fuchs EJ
    Blood; 2001 Dec; 98(12):3456-64. PubMed ID: 11719388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
    Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
    Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
    Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
    Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
    Gallon L; Mathew JM; Bontha SV; Dumur CI; Dalal P; Nadimpalli L; Maluf DG; Shetty AA; Ildstad ST; Leventhal JR; Mas VR
    J Am Soc Nephrol; 2018 Feb; 29(2):423-433. PubMed ID: 29191961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up.
    Wang X; Yang C; Hu L; Wei Z; Tang Q; Chen B; Ji Y; Xu M; Zeng Z; Rong R; Zhu T
    Ann Transl Med; 2020 Nov; 8(21):1378. PubMed ID: 33313123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitating cells as a venue to establish mixed chimerism and tolerance.
    Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
    Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
    Podestà MA; Sykes M
    Front Immunol; 2021; 12():791725. PubMed ID: 35069574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.